DYADIC INTERNATIONAL INC Increase (Decrease) in Deferred Revenue
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-03-26
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for fiscal 2024 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for fiscal 2023 was -$352.94K.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for fiscal 2022 was -$147.06K, a 129.41% decline from fiscal 2021.
- DYADIC INTERNATIONAL INC increase (decrease) in deferred revenue for fiscal 2021 was $500.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$326.10K derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | -$326.10K derived: sum of 3 quarters · filed 2025-03-26 | -$264.71K derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | -$326.10K derived: sum of 2 quarters · filed 2025-03-26 | -$264.71K derived: sum of 3 quarters · filed 2025-03-26 | -$308.82K derived: sum of 4 quarters · filed 2025-03-26 | |
| 2023-12-31 | -$326.10K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$264.71K derived: sum of 2 quarters · filed 2025-03-26 | -$308.82K derived: sum of 3 quarters · filed 2025-03-26 | -$352.94K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $61.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $17.27K derived: sum of 2 quarters · filed 2024-11-12 | -$26.85K 10-Q · filed 2024-11-12 | -$70.96K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$44.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$88.24K 10-Q · filed 2024-08-13 | -$132.35K derived: sum of 3 quarters · filed 2024-08-13 | -$176.47K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$44.12K 10-Q · filed 2024-05-14 | -$88.23K derived: sum of 2 quarters · filed 2024-05-14 | -$132.35K derived: sum of 3 quarters · filed 2024-05-14 | -$112.14K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$44.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$88.23K derived: sum of 2 quarters · filed 2024-03-28 | -$68.03K derived: sum of 3 quarters · filed 2024-03-28 | -$147.06K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$44.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$23.91K derived: sum of 2 quarters · filed 2023-11-08 | -$102.94K 10-Q · filed 2023-11-08 | $397.06K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $20.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$58.82K 10-Q · filed 2023-08-09 | $441.18K derived: sum of 3 quarters · filed 2023-08-09 | $441.18K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$79.03K 10-Q · filed 2023-05-10 | -$79.03M 10-Q · filed 2022-05-12 | $420.97K derived: sum of 2 quarters · filed 2023-05-10 | $420.97K derived: sum of 3 quarters · filed 2023-05-10 | $420.97K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $500.00K derived: sum of 2 quarters · filed 2023-03-29 | $500.00K derived: sum of 3 quarters · filed 2023-03-29 | $500.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |